This module enables investors to look at Regeneron Pharmaceuticals various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 806.1 M, Cost of Revenue of 364.4 M or Earning Before Interest and Taxes EBIT of 1.4 B, but also many exotic indicators such as Interest Coverage of 144, Long Term Debt to Equity of 0.0939 or Calculated Tax Rate of 42.4944. This module is a perfect complement to use when analyzing Regeneron Pharmaceuticals Valuation or Volatility. It can also complement various Regeneron Pharmaceuticals Technical models. Additionally take a look at analysis of Regeneron Pharmaceuticals Correlation with competitors.